Financhill
Back

Aclaris Therapeutics Stock Predictions

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Buy
73

ACRS
Aclaris Therapeutics

Last Price:
2.56
Seasonality Move:
32.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Aclaris Therapeutics Stock Forecast

  • Is Aclaris Therapeutics Stock Undervalued?
    The current Aclaris Therapeutics [ACRS] share price is $2.55. The Score for ACRS is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • ACRS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Aclaris Therapeutics Stock Go Up Next Year?

Data Unavailable

Aclaris Therapeutics Stock Rating

Data Unavailable

Aclaris Therapeutics Stock Price History

Is ACRS stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACRS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
aclaristx.com

52-Week Data

52-Week High:
2.68
52-Week Low:
0.59

Prediction Charts

Market Cap:
181.93M
Price in USD:
2.55
Volume:
627.39K
Beta:
0.34

Technical Analysis

SMA50:
1.43
SMA100:
1.33
SMA200:
1.26
52-Wk Change:
-46.37%

Stock Predictions

  • Is Aclaris Therapeutics stock public?
    Yes, Aclaris Therapeutics is a publicly traded company.
  • What is the Aclaris Therapeutics stock quote today?
    The Aclaris Therapeutics stock price is 2.55 USD today.
  • How to buy Aclaris Therapeutics stock online?
    You can buy Aclaris Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-24 1.28 1.29 1.29 1.26
Oct-25 1.30 1.69 1.71 1.27
Oct-28 1.55 1.61 1.65 1.52
Oct-29 1.60 1.71 1.87 1.59
Oct-30 1.68 1.80 1.84 1.65
Oct-31 1.82 1.81 1.94 1.80
Nov-1 1.81 2.09 2.13 1.77
Nov-4 2.09 2.18 2.23 2.04
Nov-5 2.18 2.22 2.31 2.15
Nov-6 2.24 2.27 2.35 2.19
Nov-7 2.27 2.45 2.55 2.26
Nov-8 2.48 2.63 2.67 2.48
Nov-11 2.67 2.63 2.68 2.09
Nov-12 2.48 2.55 2.59 2.34

Aclaris Therapeutics Earnings

Data Unavailable

Aclaris Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.01 per share, and an increase next year of $0.06 per share.

* Aclaris Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.